Akrevia Therapeutics, a privately-held biopharmaceutical company focused on developing highly-potent, tumour-targeted immuno-oncology therapeutics, announced yesterday that it has named Joseph Farmer as its new Chief Operating Officer.
Farmer will lead Akrevia's business development, finance, administrative, and business operations functions. He will report to Rene Russo, PharmD, Akrevia's Chief Executive Officer.
Farmer is a biopharma executive with more than 20 years of industry experience. Prior to joining Akrevia, he most recently served as Senior Vice President, General Counsel, and Corporate Secretary at Tesaro, Inc. Prior to Tesaro, he was Chief Corporate Counsel and Assistant Secretary at Cubist Pharmaceuticals Inc.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer